《中华保健医学杂志》投稿须知

合集下载

《中华预防医学杂志》编辑部网络在线投稿须知

《中华预防医学杂志》编辑部网络在线投稿须知

《中华预防医学杂志》编辑部网络在线投稿须知《中华预防医学杂志》是中华医学会主办的高级综合性预防医学学术期刊,以广大预防医学工作者为主要读者对象。

本刊实行同行审稿制。

一、本刊欢迎下列稿件1、劳动卫生、环境卫生、营养与食品卫生、儿童青少年卫生、放射卫生、卫生毒理、流行病学、卫生统计、社会医学、疾病监测与计划免疫、疾病预防与健康促进、卫生保健以及卫生化学与检验技术等科学研究和有效的防制经验总结。

2、预防医学科学研究的新理论、新技术、新成果和新方法介绍。

3、与预防医学有关的边缘科学、软科学和基础理论研究的文稿。

4、具有指导意义的述评和专论,有实际参考价值的国内外文献综述、学术讲座、专题讨论、笔谈和书评。

5、国内外学术交流信息、会议纪要、科研动态和产品信息、广告等。

二、对文稿的要求1篇幅: 论著、综述类一般不超过5000字,经验交流不超过3000字,简报、病例报告不超过2000字。

邮寄稿件请作者以A4纸张打印并核对清楚,尤其标点符号,标点符号占一格,英文应隔行打印。

为提高审稿效率,条件允许的作者请优先选择电子邮件的方式投稿。

不准一稿多投,文责自负,自留底稿,一律不退。

2来稿应具有创造性、实用性、先进性、科学性和逻辑性,要求资料真实、论点明确、结构严谨、层次清楚、文字精炼、数据准确,重点说明一个或几个问题,有理论或实际意义,必要时应做统计学处理。

3作者:论文署名不宜过多,应是参与选题和设计、参与具体工作、能对研究结果负责者,仅参与获得资金或收集资料者不能列为作者,仅对科研小组进行一般性管理者也不宜列为作者。

以脚注形式注明作者单位名称及邮政编码。

集体署名的文章必须明确对该文负责的关键人物。

虽对本文有贡献,但不具备作者条件者在文后志谢。

作者姓名排序需在投稿时确定,一经编排,不得更改。

4文题:力求简明准确地反映文章主题。

一般不超过20个字,以不设副标题为好。

一般不使用缩略语。

5摘要:论著需附400字左右的中、英文摘要,内容必须包括目的、方法、结果(应给出主要数据)、结论四部分,各部分冠以相应的标题。

《中华检验医学杂志》网上投稿须知

《中华检验医学杂志》网上投稿须知

《中华检验医学杂志》网上投稿须知《中华检验医学杂志》投稿须知期刊简介:中华检验医学杂志为中华医学会主办的检验医学专业学术期刊,以广大中高级检验医学人员和临床医师为主要读者对象,报道我国检验医学领域领先的科研成果。

本刊的办刊宗旨是贯彻党和国家的卫生工作方针政策,贯彻理论与实践相结合的方针,反映我国检验医学科研工作的重大进展,促进国内外检验医学学术交流。

刊名:《中华检验医学杂志》,英文:《Chinese Journal of Laboratory Medicine》主办单位:中华医学会。

编辑单位:北京市东四西大街42号《中华检验医学》杂志编辑部。

地址:北京市朝阳区十里堡甘露西园1号楼314室。

邮政编码:100710。

电子邮件: zhjyyxzz@ 。

国际刊号:1009-9158。

国内刊号:11-4452/R。

期刊种类:月刊。

栏目设置:本刊设有述评、专家论坛、新进展、论著、科研快讯、会议纪要、管理、综述、讲座、继续教育园地、争鸣与讨论、国内外学术动态等栏目。

欢迎踊跃投稿,来稿经专家审核后择优刊用。

一、投稿要求和注意事项1、投稿方式。

电子邮件投稿(即网络投稿)请用Word格式的附件来邮;邮寄来稿请尽量用小四号字打印在A4纸上,凡字迹潦草、涂改不清的稿件,恕不受理。

来稿须附单位推荐信(电子邮件投稿请拍照后以JPG格式的附件来邮),作者单位对文稿的真实性和保密性负责,并声明未一稿两投、不涉及保密、署名无争议等项,并注明第一作者姓名、性别、学历、职称、职务、单位、地址及邮码务必写清楚。

多作者稿署名时须征得其他作者同意,排好先后次序,接《稿件录用通知书》后不再进行改动。

为加快稿件处理速度、提高工作效率,条件允许的作者请尽量优先选择电子邮件的方式投稿,本刊全国统一投稿电子邮箱: zhjyyxzz@ 。

请作者尽量勿选择邮寄稿件,以免遗失或延误时间。

热忱欢迎广大读者踊跃投稿和订阅。

2、稿件沟通。

来稿一经接受刊登,有关稿件沟通事宜,编辑部均与第一作者或通讯作者通过电子邮件方式进行联系,作者接收本刊《来稿录用通知书》后,由第一作者或通讯作者通过回复电子邮件方式,进行同意稿件在本刊发表的授权意愿。

欢迎订阅《中华保健医学杂志》

欢迎订阅《中华保健医学杂志》

・60・中华保健医学杂志2021年2月第23卷第1期Chin J Health Care Med,February2021,Vol23,No.1由于患者患病之后自我角色出现了变化,乳腺癌手术带来的身体缺损以及痛苦的化疗反应削弱了患者的自我控制感,使个体的自尊心受到打击,弱者感觉加重,被照顾的心态明显增多,自我决策、自我解压的能力发挥不足#16$%相反,多渠道自我管理组被鼓励发挥主动性"积极参与,患者从被动的依从身份转换为与医护人员共同决策的身份,自我效能和生活态度互为因果,自我效能感增强,生活态度乐观积极,不过分关注治疗过程中的不适感,提高了患者的生活质量%相关性分析也证实,正性态度"自我决策等自我效能各维度均与化疗后患者生活质量提升正相关%国外研究者以CHARGE方式开展乳腺癌自我管理,即选择一个关注点(Choose a concern';获取信息(Have the information);评价环境((Assess the situation';记录计划(Record the plan);获取自信和洞察力(Gain confidence and insight);评估过程(Evaluate your progress),通过小组讨论、电话沟通方式提高患者的自我效能#1G$%本研究中与患者的面谈沟通设计为按照确立问题、情感表达、设立目标"制订计划"效果评估5个环节进行,遵循帮助患者恢复自信心"提高自我决策能力"提高自护能力的目标,采用这5个步骤实施干预效果较为肯定%总体而言,综合书写日记、正念冥想"自助小组等方法,通过线上APP、微信群和线下面谈多渠道给予患者专业的支持,可以明显提升患者的自我效能,进而提高乳腺癌术后化疗患者的生活质量%参考文献[1]何咏竞,孙国平.乳腺癌术后复发时间与临床因素的相关性分析[J].临床外科杂志,2018,26(1):35-38.[2]中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2015版)[J],中国癌症杂志,2015,25(9):692-754.[3]张泽淳,吕海通,吴智勇.乳腺癌化疗联合内分泌治疗的新进展[J].肿瘤防治研究,2018,45(2):114-118.[4]马瓅,曹仲茹,华婧,等.跨理论模型联合信息支持对乳腺癌化疗患者自我管理效能感、应对方式及癌因性疲乏的影响[J].中华现代护理杂志,2017,23(5):617-622.[5]张丽芹,张丽华,陈霞,等.自我管理教育对社区老年2型糖尿病患者生活质量的影响[J].中国老年学杂志,2017,37(3):731-733.[6]张晋.自我管理支持改善老年慢性心衰生活质量价值[J].国际医药卫生导报,2017,23(15):2387-2389.[7]张娜.自我管理教育对乳腺癌患者术后患肢功能恢复的影响[J].中国卫生产业,2018,15(7):75-76.[8]Kim M,Lee K.Development of empowerment program forpersons with chronic mental illness and evaluation of impact[J].J Korean Acad Nurs,2015,45(6):834-845.[9]Barlow J,Wright C,Sheasby J,et al.Self-management approachesfor people with chronic conditions: a review[J].Patient Educ Couns,2002,48(2):177-187.[10]周海舒.Orem支持一教育系统理论应用化疗期乳腺癌患者自我管理的研究[D].长春:吉林大学,2013.[11]臧苑彤,宁香香,尹志勤.自我管理对乳腺癌术后病人化疗期间症状的影响[J]•护理研究,2013,27(5):432-434.[12]李晓瑾,李文姬,周春兰.乳腺癌术后化疗患者心理困扰与疾病不确定感的相关性[J].广东医学,2019,40(18):2645-2649.[13]Shin S,Park H.Effect of empowerment on the quality of life ofthe survivors of breast cancer: The moderating effect of self-help group participation[J].Jpn J Nurs Sci,2017,14(4):311-319.[14]单墨水,赵忠凯,杨毅,等.正念对乳腺癌化疗患者情绪和生活质量的影响[J]•中华保健医学杂志,2019,21(5):400-404.[15]敖炼.基于赋能理论的自我管理模式在乳腺癌术后化疗患者中的应用研究#D].太原:山西医科大学,2019.[16]张飞艳,宋丽华.乳腺癌患者的心理状况及其心理干预[J].中华肿瘤防治杂志, 2017, 24(3):212-216.[17]CimPrich B,Janz NK,Northouse L,et al.Taking charge:a self­management programe for women following breast cancer treatment[J].Psychooncology,2005,14(9):704-717.(收稿日期:2020-09-12,修回日期:2020-11-18)UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU欢迎订阅《中华保健医学杂志》《中华保健医学杂志》为中央军委后勤保障部卫生局主管,中央军委后勤保障部卫生局保健办主办,解放军总医院承办,《中华保健医学杂志》编辑委员会编辑、出版的全国性中老年保健医学学术期刊,是从事医疗保健工作的科研和临床医护人员进行学术交流的重要平台%本刊面向全国各级医院、疗养院医疗保健工作者及门诊部、基层干休所医务人员,是从事医疗保健工作和基层医务工作者的良师益友%我们热诚地欢迎您订阅本刊并成为本刊的热心读者!本刊为双月刊,大16开本,80页,每双月月末出版,每期订价12元,全年72元,邮发代号80-614,国内统一刊号CN11-5698/R,国际标准刊号ISSN1674-3245%欲订购本刊的单位及读者请到各地邮局办理%。

《解放军保健医学杂志》投稿须知指南

《解放军保健医学杂志》投稿须知指南

《解放军保健医学杂志》投稿须知指南1投稿1.1请作者投稿前仔细阅读本稿约。

一旦投稿,即被自动认为全部作者已阅读本稿约,并已理解和接受本稿约的内容和要求。

1.2本刊现已采用电子邮箱处理稿件,作者请通过电子邮箱进行投稿:jfjbjyxzz@ 。

来稿须经作者所在单位审查(注明材料真实可靠,无一稿多投和无机密资料泄密等),并附证明材料或书面声明。

作者可推荐2~3名审稿人,并附推荐审稿人的通讯地址或联系方式。

对于审稿认定有重要创新的论文将以最快的速度刊出;对于基金资助课题论文,审稿通过后将优先发表。

1.3编辑部收到稿件后1个月内发出稿件处理意见。

超过2个月未收到稿件处理意见的作者请及时向编辑部查询。

如欲另投他刊,请及时和本刊联系。

切勿一稿两投,一旦发现,将立即退稿;如果发现一稿两用,本刊将刊登该文系重复发表的声明,并在两年内拒绝该论文作者以第一作者身份的任何来稿。

1.4来稿一经接受,文责一律由作者自负。

依照我国《著作权法》的有关规定,本刊对来稿有删改权。

修改稿逾1个月不返回本编辑部而事先未申明原因者,视作自动撤稿。

1.5本刊已加入《中国学术期刊(光盘版)》(CAJ-CD)、《中国期刊全文数据库》、《万方数据——数字化期刊群》等全文数据库系统。

凡被本刊录用的稿件,将由本刊统一纳入上述信息服务系统。

如不同意将自己的稿件纳入光盘版或因特网传送交流的作者,请在投稿时书面声明。

1.6确定刊用的稿件将依所占版面与插图数量收取版面费(刊印彩图者需另付彩图印制工本费),请在收到付费通知后七个工作日内付款;文稿刊出后酌致稿酬(已含光盘版、网络版稿酬),并赠送当期杂志2册。

2撰稿2.1文题名应恰当简明地反映文章的特定内容和研究的特色,文题要恰如其分,不可夸大,尽可能具体、明确,避免使用“……的研究”等没有实质意义的词语,不使用非公知的缩略词、缩写字符和代号等;一般不用副题名。

中文题名一般不超过20个汉字;英文题名应与中文题名含义一致,一般不超过10个实词。

中华医学杂志稿约

中华医学杂志稿约
3.来稿要求:按照中华医学会杂志社的要求,中华医学杂志从2010年一律实行网上投稿,请登陆http://www.nmjc.net.
Crl(中华医学杂志网站),点击在线投摘进行网上投稿。或者登陆网址:http://www.cn'la.org.cn/ywzx/ymx.asp。同时将单位
介绍信邮寄到本刊编辑部(北京东四西大街42号,100710)。作者随时可上网查询稿件的处理情况。
者姓名列于文末;协作组成员在文后、参考文献前一一列出。作者中若有外籍作者,应附其本人同意的书面材料,并应用其本
国文字和中文同时注明其通讯地址,地名以国家公布的地图上的英文名为准。 3.摘要:所有论文均需附中、英文摘要,论著类论文摘要采用结构式摘要必须包括目的、方法、结果(应给出主要数据)及
结论四部分,各部分冠以相应的标题。述评、专家论坛、技术交流、综述等采用指示性摘要。采用第三人称撰写,不用“本文”
字,英文题名不宜超过lO个实词。中、英文题名含义应一致。 2.作者署名:作者姓名写在题名下,排序应在投稿时确定,在编排过程中不应再作更改;作者单位名称、邮政编码及通讯
作者的姓名、单位名称、邮政编码等脚注于题名页。作者应是:(1)参与选题和设计,或参与资料的分析和解释者;(2)起草或
修改论文中关键性理论或其他主要内容者;(3)能对编辑部的修改意见进行核修,在学术上进行答辩,并最终同意该文发表 者。以上3条均需具备。集体署名的文章必须明确通讯作者,通讯作者的姓名、工作单位和邮政编码脚注于论文题名页;整理
现代先进技术、及时交流防病治病经验、大力普及医学科技新知为己任。本刊的办刊方针是理论与实践相结合,提高与普及相结
合,倡导百花齐放、百家争鸣。中华医学杂志实行严格的同行专家审稿制度,依据稿件学术质量,公平、客观的取舍稿件。

欢迎订阅《中华保健医学杂志》

欢迎订阅《中华保健医学杂志》

•668•中华保健医学杂志2020年12月第22卷第6期Chin J Health Care Med,December2020,Vol22,No.6(8):94-97.[11]Wen F, An C, Wu X,et al.MiR-34a regulates mitochondrialcontent and fat ectopic deposition induced by resistin through the AMPK/PPAR a pathway in HepG2cells[J].Int J BiochemCell Biol,2018,94(18):133-135.[12]朱伏丽,单庆文.白细胞介素-17在非酒精性脂肪性肝病发病机制中的研究进展[J].中华实用儿科临床杂志,2019,34(19):1508-1511.[13]陈巧杰,武少坤,邬耀军,等.miR-34a对脂肪干细胞移植治疗跟腱炎的影响[J].中国病理生理杂志,2018,34(10):164-169.+14]Huang X,Gao Y,Qin J,et al.The mechanism of long non-coding RNA MEG3for hepatic ischemia-reperfusion: mediated by miR-34a/Nrf2signaling pathway[J].J Cell Biochem,2018,119(1):1163-1172.[15]孔思明,张晓琳,叶菲.内质网应激与非酒精性脂肪性肝病[J].国际药学研究杂志,2016,43(2)*234-238,248.[16]杨以琳,魏毅,张贵平,等.白芍总苷对NAFLD大鼠HMGB1,TLR4通路的干预作用[J].中国实验方剂学杂志,2017,6(14):154-159.[17]傅求真,寇丹,白玉蓉,等•血清氧化应激指标、脂联素、HMGB1与NAFLD的关系研究[J].解放军预防医学杂志, 2019,37(4):51-52.[18]Xiao f,Xin Y,Feng N,et al.ROS-responsive polymeric micellesfor triggered simultaneous delivery of plk1inhibitor/mir-34a and effective synergistic therapy in pancreatic cancer[J].ACS AppMater Interfaces,2019,11(16):14647-14659.[19]陈彬,林海雪.多烯磷脂酰胆碱对非酒精性脂肪肝小鼠的干预及其对肝锌指蛋白A20表达的影响[J].中国临床药理学杂志,2018,12(11):1353-1356.[20]熊海容,吴利春,段丽,等.竹节参总皂苷通过调节miR-34a/PPAR a干预小鼠脂肪肝的作用研究[J].现代食品科技,2017,33(8):28-29.[21]Zhang Q B,Qing Y F,Yin C C,et al.Mice with miR-146adeficiency develop severe gouty arthritis via dysregulation of TRAF6,IRAK1and NALP3inflammasome[J].Arthritis Res Ther,2018,20(1):45-47.[22]Reynolds RH,Petersen MH,Willert CW,et al.Perturbations inthe p53/miR-34a/SIRT1pathway in the R6/2Huntington's disease model[J].Mol Cell Neurosci,2018,88(14):118-129.[23]De Souza CO,Teixeira AAS,Biondo LA,et al.Palmitoleic acidImproves Metabolic Functions in Fatty Liver by PPAR a-Dependent AMPK Activation[J].J Cell Physiol,2017,232(8) :2168-2177.[24]郭行雅.肝脂肪变性相关环状RNA的筛选及功能研究[D].上海:上海交通大学,2017.[25]肖阳,侯云鹤,尹鑫,等.人参皂苷Rg1干预非酒精性脂肪肝模型大鼠肝细胞的凋亡[J].中国组织工程研究,2019,23(3):384-390.[26]王艳景,谷征,李圆圆.MicroRNA-29b对肝纤维化及肝星状细胞增殖、凋亡的影响[J].中国现代医学杂志,2018,28(32):23-30.[27]余亮,江惠丽,刘豪杰,等.褐藻多糖硫酸酯通过调控HDAC1基因的表达促进胃癌细胞凋亡[J].中国病理生理杂志,2019,35(6):1075-1080.[28]Sun T Y,Xie H J,Li Z, et al.miR-34a regulates HDAC1expression to affect the proliferation and apoptosis of hepatocellular carcinoma[J].Am J Transl Res, 2017, 9(1):103-114.[29]Zhu J N,Fu Y H,Hu Z Q,et al.Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity[J].Sci Rep,2017,7(1):118-120.[30]田慧群,刘朝奇.非酒精性脂肪性肝病中Toll样受体活化与microRNA调控的研究进展[J].细胞与分子免疫学杂志,2015,31(3):428-431.[31]陈艳,王小清,郝海荣,等.淮安地区离退休人员社会经济地位与非酒精性脂肪性肝病关系研究[J].中国全科医学,2019,22(9):1033-1038.[32]肖海英,郑雪莲,汪安江.非酒精性脂肪性肝病治疗进展[J].中国实用内科杂志,2017,39(12):1069-1074.[33]林立,孙华胜,毛乾国,等.非酒精性脂肪肝同病异证与肝活检病理学的相关性研究[J].中华中医药杂志,2019,34(4):1462-1465.[34]杨蕊旭,胡春秀,宓余强,等.非酒精性脂肪性肝病患者血清脂质组学研究[J].中华肝脏病杂志,2017,35(25):127-129. [35]丁玉平,张文,夏时海,等.非酒精性脂肪性肝病生化特点及其与相关疾病的关系[J].胃肠病学和肝病学杂志,2018,27(8):936-941.(收稿日期:2020-05-22;修回日期:2020-07-11)UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUU欢迎订阅《中华保健医学杂志》《中华保健医学杂志》为中央军委后勤保障部卫生局主管,中央军委后勤保障部卫生局保健办主办,解放军总医院承办,《中华保健医学杂志》编辑委员会编辑、出版的全国性中老年保健医学学术期刊,是从事医疗保健工作的科研和临床医护人员进行学术交流的重要平台&本刊面向全国各级医院、疗养院医疗保健工作者及门诊部、基层干休所医务人员,是从事医疗保健工作和基层医务工作者的良师益友&我们热诚地欢迎您订阅本刊并成为本刊的热心读者!本刊为双月刊,大16开本,80页,每双月月末出版,每期订价12元,全年72元,邮发代号80-614,国内统一刊号CN11-5698/R,国际标准刊号ISSN1674-3245&欲订购本刊的单位及读者请到各地邮局办理&。

中华医学杂志英文版投稿须知

中华医学杂志英文版投稿须知

Instructions for authorsChinese Medical Journal (CMJ) is an international, peer-reviewed general medical journal published in English semimonthly by the Chinese Medical Association and distributed worldwide. Manuscripts are welcome from any part of the world.MANUSCRIPT INFORMATIONManuscript requirementsManuscripts submitted to CMJ should meet the following criteria: the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data.Manuscript submissionAuthors are required to submit their manuscripts online at .Previous publication or duplicate submissionManuscripts are considered with the understanding that they have not been published previously and are not under consideration by another publication. Copies of possibly duplicative materials that have been previously published or are being considered elsewhere must be provided at the time of manuscript submission.Previous presentationA complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) can be considered.CATEGORIES OF ARTICLESCMJ publishes editorial, original article, review article, medical progress, brief report,viewpoint, case report, letter, and many other categories of articles. Topics of interest include all subjects that relate to the practice of medicine and research.EditorialThese are usually commissioned, however, unsolicited editorials are welcome. We are keen to consider editorials or ideas for editorials from authors outside China. Editorials should be up to 2000 words long with no more than 25 references.Original articleManuscripts on epidemiological studies, studies of social medicine, clinical trials, especially large scale randomized controlled trials are welcome. Each manuscript should clearly state an objective or hypothesis, the methods, the main results of the study and the conclusions. The length is limited to 2000–4000words (not including tables, figures, and references).More than 20 references are encouraged to be cited in this kind of articles.Meta analysisOnly results of meta analysis are reported in this kind of article. The length of the article is within 2000–4000 words (not including tables, figures, and references). Medical progressThis kind of article is mainly solicited, but we also consider unsolicited articles. The length of the article is within 2000–4000 words (not including tables, figures, and references).Review articleReview articles include systematic, critical assessments of literature and data sources pertaining to different medical topics, such as cause, diagnosis, prognosis, therapy, or prevention, etc.The length is limited to 2000–4000words (not including tables, figures, and references).Brief reportThese articles are short reports of original studies. They should not exceed 2500 words with no more than 2 tables and/or two illustrations and 15 references.Clinical experienceAuthors of these articles provide their experiences for diagnosis, treatment or prevention of diseases. The length is up to 2500 words with no more than 2 tables and/or two illustrations and 15 references.ViewpointPersonal views are welcome and the length should be 1000–3000 words (not including tables, figures, and references). Authors of this type of articles should sign their real names; no anonymous pieces are published.Case reportAuthors usually describe one to three patients or a single family. The text is limited to no more than 2500 words, and up to 15 references.Clinical solutionsThe articles are evidence-based reviews of topics relevant to practicing physicians. Articles in this series should include the following sections: case report, clinical overview, strategies, clinical difficulties, and author’s personal opinions. The text is limited to 3000 words and a small number of figures and tables. Images for diagnosisAuthors can provide here with typical images of common or uncommon medical conditions. This feature is intended to capture the sense of visual discovery and variety that physicians experience. It is not intended as a vehicle for case reports.LetterLetters to editors discussing a recent CMJ article should be received within 3 months of the article’s publication and should not exceed 500 words of text and 5 references. Letters should also be submitted online.AUTHOR INFORMATIONDesignate a corresponding author and provide a complete address,telephone and fax numbers, and E-mail address.Authorship requirementsEach author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based on(1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published.Conditions 1, 2, and 3 must all be met.1Group authorshipIf authorship is attributed to a group, all members of the group must meet the full criteria and requirements for authorship as described above. A group must designate at least one individual as corresponding author. Other group members may be listed in an Acknowledgment.Conflicts of interestAuthors should indicate relevant conflicts of interest, including specific financial interests relevant to the subject of their manuscript, in their covering letter. Authors without relevant financial interests in the manuscript should indicate no such interest.EDITORIAL REVIEW AND PUBLICATIONPeer reviewA CMJ editor reviews submitted manuscripts initially. Manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to expert consultants for peer review. Peer reviewer identities are kept confidential.The manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. We encourage authors to suggest the names of possible reviewers, but we reserve the right of final selection. Rejected manuscriptsRejected manuscripts and reasons for rejection can be found online. EditingAccepted manuscripts are copyedited first by native speakers and then by CMJ editors according to CMJ style and returned to the author for approval. Authors are responsible for all statements made in their work, including changes made by the editor and authorized by the corresponding author.PublicationAuthors are required to pay page fee if their manuscripts are accepted for publication. The publisher will provide the author (s) 2 copies of the journal free of charge.CopyrightThe Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of the Chinese Medical Association and may not be published elsewhere without written permission. Chinese Medical Association keeps the right to use these manuscripts in any form, including print, video, audio, and digital.MANUSCRIPT PREPARATIONManuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by the International Committee of Medical Journal Editors (ICMJE) ().Submit the original manuscript online; use 1 side of standard-sized page and 1.5 cm margins.For Chinese authors, submission of a Chinese version of the manuscript (or abstract) is recommended.Use only 10- or 12-point font size.On the title page include the full names and affiliations of all authors. If an author’s affiliation has changed since the work was done, list the new affiliation as well. Titles should be concise and descriptive. The name, address, telephone number, fax number, and E-mail address of the correspondence author should be addressed. Any grant support that requires acknowledgment should be mentioned on this page.Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury. All hematological and clinical chemistry measurements should be reported in the metric system in terms of the International System Units (SI).Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is directly relevant to the discussion.Do not use abbreviations in the title or abstract and limit their use in the text.A covering letter signed by all authors includes(1) information on prior or duplicate publication or submission elsewhere of any part of the study; (2) the statement that the manuscript has been read and approved by all the authors and that the criteria for authorship have been met; (3) the statement on financial or other conflict of interests; and (4) any suggestions such as referring possible unqualified reviewers due to conflict of interests, etc. The corresponding author must sign the acknowledgment statement. Authors should obtain written permission from all individuals named in an acknowledgment.JOURNAL STYLETablesTables should be simple and no duplicate information should appear in the text of the article. Tables should be numbered consecutively, and headed by a concise title. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Forfootnotes use the following symbols in this sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡.FiguresComplete sets of illustrations must be submitted with legends typed on the same page. Only clear photographs are acceptable. All lettering must be legible after reduction to column size. Magnification and staining should be indicated when pertinent. AbbreviationsUse only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.Ethical requirementFor experimental investigations of human subjects, state in the Methods section that an appropriate institutional review board approved the project. For those investigators who do not have formal ethics review committees,the principles outlined in the Declaration of Helsinki2 should be followed. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants.Patient descriptions, photographs, and pedigreesInclude a signed statement of informed consent to publish (in print and online) patient descriptions, photographs, and pedigrees from all persons (parents or legal guardians for minors) who can be identified in such written descriptions, photographs, or pedigrees. Such persons should be shown the manuscript before its submission.Permissions required to reproduce or adapt material Acknowledge all text, illustrations, and tables adapted or reproduced from other publications and submit permission from the original publishers(or other copyright owner) to republish in print, online, and licensed versions of CMJ.ReferencesNumber references in the order they appear in the text; do not alphabetize. In text, tables, and legends, identify references with superscript Arabic numerals. When listing references,abbreviate titles of journals according to Medline. Note: List authors and/or editors up to 6; if more than 6, list the first 6 authors followed by et al.Examples of reference style:1. Liu XP, Long DY, Dong JZ, Liu XQ, Fang DP, Hao P, et al. Recurrent atrial tachycardia and atrial fibrillation after circumferential pulmonary vein a blation: What’s the difference? Chin Med J 2005; 118: 1773-1778.2. Xie SZ, Gu MJ, Cheng YP. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm. Chin J Obstet Gynecol (Chin)* 1998; 33: 113-114.3. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974: 457-472.4. Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11 Suppl 2: s369-s378.5. Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2): 89-97.6. Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995;32 (Pt 3): 303-306.7. Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-114.8. Cumulative number of reported cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. (Accessed April 9, 2003 at http://www.who.int/csr/sarscountry/ 2003_04_04/en/.)*: It is especially needed to note “(Chin)” for articles published in Chinese.Authors are responsible for the accuracy and completeness of their references and for correct citation of the text.REPORT OF ORIGINAL DATAAbstractInclude a structured abstract of no more than 300words for original articles, meta analysis, brief report, clinical experience (Background, Methods, Results, Conclusions) and review articles (Objective, Data sources, Study selection, Results, Conclusions); an informative abstract for medical progress, viewpoint, case report, clinical solutions and images for diagnosis.KeywordsThree to 6 words or short phrases should be provided at the top of the abstract page as keywords. Terms from the medical subject heading (MeSH) list of Medline should be used; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used.IntroductionIntroduction should be short and arresting. State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.MethodsDescribe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex, and other important characteristics of the subjects.Iden tify the methods, apparatus (list the manufacturer’s name and original country in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate theirlimitations. Identify precisely all drugs and chemicals used, including generic name (s), dose (s), and route (s) of administration.Reports of randomized clinical trials should present information on all major study elements including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding). Authors are recommended to refer to the CONSORT Statement 3 for details.ResultsOverall describe the major findings of the study. Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. DiscussionSummarize the major findings. Discuss possible problems with the methods used. Compare your results with previous work. Discuss the clinical and scientific (if any) implications of your findings and their limitations. Suggest further work. Produce a succinct conclusion.MANUSCRIPT CHECKLISTSubmit complete text of your manuscript online (including tables, figures, etc), in addition, domestic authors should submit Chinese version of the complete text or its abstract.Review the sequence: covering letter, title page, key words and abstract, text, acknowledgments, references, tables, legends for illustrations.Check all references for accuracy and completeness. Put references in proper format in numerical order, making sure each is cited in the text.Include written permission from each individual identified as a source for personal communication.Include informed consent forms for identifiable patient descriptions, photographs and pedigrees.Keep copies of everything submitted.Manuscript inquiriesTel:86-10-85158321.Fax:86-10-85158333.Email:***********. cn.REFERENCES1.International Committee of Medical Journal Editors. Uniformrequirements for manuscripts submitted to biomedical journals.(Accessed September 10, 2009 at: )2.World Medical Association. Declaration of Helsinki: Ethicalprinciples for medical research involving human subjects.(Accessed September 6, 2005 at: /e/policy/ pdf/ 17c.pdf)3.Schulz KF, Altman DG, Moher D, for the CONSORT Group.The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (Accessed October 28, 2010 at: http://www.consort- )。

《中国初级卫生保健》投稿要求及稿件处理

《中国初级卫生保健》投稿要求及稿件处理

中国初级卫生保健2021年6月第35卷第6期(总第426期)素、体格指标、代谢指标及临床症状均有显著改善作用,具有潜在降低代谢综合征风险的作用。

脂肪肝转归,2217年检出脂肪肝的人群2219年脂肪肝再次检出率为50.33%,远远高于2017年未检出而2019年检出人群的检出率(5.66%),可能的原因是虽然经历了2年,但是有一半以上的脂肪肝患者并未治愈,或者是虽然治愈脂肪肝患者,再次患脂肪肝的风险要远远高于非脂肪肝患者。

对不同组2017年和2019年代谢综合征检出率比较,阴性组和转阳组差异有统计学意义(X阴性组=2558,X转阳组=52,P V165),转阴组和转阳组差异无统计学意义(x2转阴组=526,X阳性组=533,P a LO),这可能与219年代谢综合征检出率(22.37%)高于2017年的检出率(20.34%),而转阴组虽然脂肪肝已治愈但因生活习惯并未显著改变代谢综合征组分并不会快速恢复正常有关。

本研究结果显示,NAFLD检出率和检出风险都随着代谢综合征异常成分检出数量增加呈快速上升趋势。

提示NAFLD是代谢综合征在肝脏的表现与胰岛素抵抗和2型糖尿病、中心性肥胖、高脂血症、高血压以及其他与胰岛素抵抗相关的病理状态,如多囊卵巢综合征相关。

在多因素分析中,超重或肥胖与非酒精性脂肪肝关系最强,是脂肪肝最重要的危险因素,可能的机制为肥胖导致脂联素水平降低、瘦素水平升高,加重了胰岛素抵抗[8-I o因此,降低体脂量和腰围是预防和治疗NAFLD及其并发症最为重要的治疗措施3社区卫生服务中心是居民的“健康守门人”,推动以社区为基础的慢性病风险筛查、症状干预、诊断治疗、随访管理、健康教育和康复等服务的“一体化”管理,对于提升社区卫生服务中心的服务能力至关重要。

当前上海市社区卫生提供的居民免费体检,对于提高疾病的早期发现、早期诊断具有重要意义,但是对体检结果进行动态跟踪,提供持续的慢性病综合干预阿仍然是当前的短板。

《中华保健医学杂志》投稿须知

《中华保健医学杂志》投稿须知

《中华保健医学杂志》投稿须知
佚名
【期刊名称】《中华保健医学杂志》
【年(卷),期】2024(26)2
【摘要】《中华保健医学杂志》是由国家新闻出版署批准的国内外公开发行的中老年保健医学综合性学术期刊。

主要内容为中老年疾病与保健的国内外学术动态、基础理论研究、临床实践经验以及基础与临床紧密结合的研究成果。

旨在加强本学科国内外学术交流,提高保健工作者的业务学术水平,促进老年保健医学的发展,更好地为中老年医疗保健事业服务。

设有专家述评、论著、经验交流、病例报告、综述等栏目。

【总页数】1页(P197-197)
【正文语种】中文
【中图分类】G23
【相关文献】
1.欢迎投稿、欢迎订阅《中华保健医学杂志》
2.《中华保健医学杂志》投稿须知
3.《中华保健医学杂志》投稿须知
4.《中华保健医学杂志》投稿须知
5.《中华保健医学杂志》投稿须知
因版权原因,仅展示原文概要,查看原文内容请购买。

《中华医学》杂志投稿须知

《中华医学》杂志投稿须知

《中华医学》杂志投稿须知《中华医学杂志》简介《中华医学杂志》(ISSN 0376-2491, CN 11-2137/R)创刊于中华医学会成立的1915年。

创刊之初是中、英文双语期刊,英文刊名为National Medical Journal of China。

1932年,《中华医学杂志》的英文部分与中国博医会的英文杂志China Medical Journal (博医会报)合并,以Chinese Medical Journal为刊名出版;中文部分仍称《中华医学杂志》继续出版,并继续保留National Medical Journal of China的英文刊名,现在,在中华医学杂志的论著类文章中依然保留英文的作者姓名、通讯地址和严格的英文摘要。

作为中国卫生部中华医学会的会刊、中华医学会主办的一木医学综合性学术期刊,中华医学杂志创刊90年来始终坚持以服务广大会员和医药卫生科技人员、促进国内外医学学术交流和医学事业发展为宗旨,全面反映中国医学最新的科研成果,紧密跟踪世界医学科技进步的潮流,理论与实践结合,提高与普及并重,积极推广医药卫生领域的新技术、新成果,及时交流防病治病的新经验,大力普及医学科技新知识,为提高中国广大医药卫生人员的思想和职业道德修养、医学科学理论和业务技术水平,推动中国医学科技进步和知识创新,以及繁荣中国医学科技出版事业,发挥了重要作用。

历经数代人的努力,《中华医学杂志》形成了科学性强、权威度高、影响力大、覆盖面广的刊物特色,树立了良好的社会形象,在中国医学界享有很高的声誉。

中国国家图书馆、中国科技信息研究所、中国医学科学院科技信息研究所、中国科学文献计量评价研究中心等国家科技信息情报部门均把中华医学杂志列为核心期刊。

据中国科技论文与引文数据库和中国科学引文数据库提供的资料,中华医学杂志的被引频次连续数年在中国医学期刊中位居前十名(由《中国科技期刊引证报告》,2003年是医学类第五名,2004年是医学类第三名),影响因子连续五年呈上升趋势,在综合类医学期刊中始终位居前五名(由《中国科技期刊引证报告》,1992年和1996 2003年是医学综合类第三名,2004年是医学综合类第四名)O年,中华医学杂志分别荣获首届和第二届全国优秀科技期刊一等奖;1999年荣获首届国家期刊奖;2002年荣获第二届国家期刊奖,2004年荣获第三届国家期刊奖,连续四年荣获中国百种杰出学术期刊称号。

保健医学与研究投稿经验

保健医学与研究投稿经验

保健医学与研究投稿经验
作为一名语言模型AI,我没有亲身经历投稿,但是我可以给您一些一般的建议。

在准备投稿之前,您需要:。

1、找到一个合适的期刊和投稿范围。

您可以通读一些相关领域的期刊,并了解他们的主题范围、投稿要求和评审流程,以确定哪个期刊是最适合您的文章的。

2、撰写高质量的研究文章。

您需要编写一份清晰、结构良好的文章,并确保其质量和準确性。

该文章还应该包括新颖的研究结果、应用价值、方法和数据分析。

在投稿过程中,需要注意以下几点:
1、遵循期刊的投稿要求。

2、引用正确和适当的文献。

您需要确保引用文献的准确性和时效性,并采用正确的引用格式,以确保您的文章的可信度。

3、认真回答审稿人的反馈意见。

如果您的文章被接受,但需要进行修改,您需要认真思考审稿人的反馈意见,并在回答意见时提供具体的建议和分析。

总之,投稿到保健医学期刊需要您有相关的专业知识和技能,并遵守期刊的投稿指南和要求。

如果您能够坚持不懈地努力,您的研究结果肯定会得到认可和发表的机会。

《中华养生保健杂志》投稿须知

《中华养生保健杂志》投稿须知

晋升网简介
• 晋升网( 致力于成为医务工作者晋升职称心灵导师;是目前国内收 录医学期刊、医学杂志最多最权威的医学学术平台;提供免费医学期刊在线阅读;网罗 和甄选海量优秀医学论文检索,独立研发医学在线资源分享库和医学在线模拟考试库; 整合刊类、标题、关键词检索及全文检索,并独家研发刊社管理和刊社加盟系统、在线 投稿、在线查稿、在线阅读、远程审稿、在线下载等系统;聚刊社力量,建服务平台, 让晋升网通过“专业”走入每一个医务人员的身边是我们不懈的追求目标; 晋升网() 标准 最便捷的晋升通道 最丰富的医学文献 最专业的医学服务 最高效的学习方法 最权威的医学期刊

《中华养生保健杂志》人民共和国国家中医 药管理局主管,由中华中医药学会主办,北京中医药 大学承办的中央级医疗、医药、保健导向性、权威性 期刊。本刊创办于2001年,原名《中华气功》,月刊, 规格为国际通用的大16开本,国际标准刊号ISSN10098011,国内统一刊号CN11-4536/R,邮发代号80-266, 当月01日出版, 单价5.00,全年价60.00。 《中华养生保健杂志》以弘扬祖国医药文化事业、 促进人民身体健康为办刊宗旨。坚持科学性、知识性、 趣味性和实用性于一体;坚持提高与普及相结合。

瑜伽时尚:瑜伽是时尚的,时尚属于瑜伽。写下你的 动身故事吧。2000字左右,最好附照片。 性保健之窗:男女之间的私心杂念所引发的所想、所 渴望的种种内心世界(未必是实施的),两性间不可泄露 的“机密”讯息。内容偏向新潮、前卫,含有现代两 性的新思想。以比较轻松的性爱话题为主,但不能呆 板老式的“性教育”,以性生活感悟出新鲜的内涵。 可有故事情节、议论等穿插的描述。见解新颖独到, 文风活泼;应有独创性,让人耳目一新,大开眼界。 字数2000字。 名家讲堂:每期推出一到两位国内外医学界著名专家 的演讲精华。欢迎大家提供名家、名人、名士演讲稿。

本刊作者署名和单位的写作要求

本刊作者署名和单位的写作要求

·糖尿病与并发症·DIABETES NEW WORLD 糖尿病新世界糖尿病新世界2020年8月出现异常时,Cys-C 水平会因此升高[6]。

CRP 在健康人体血清中的浓度极低,而当机体受到组织损伤或炎症性刺激时,肝细胞会合成一种急性时相蛋白CRP,该蛋白有着较高的敏感性,可作为炎性标志物,临床常用于评估疾病的活动性与疗效监测。

有研究发现[7],炎症在2型糖尿病的发展中起到一定的作用,而2型糖尿病肾病患者除了出现血糖、血脂紊乱的症状外,还存在炎性损伤的情况,所以临床上可用CRP 作为诊断2型糖尿病肾病的辅助指标。

Hcy 在血浆中分有氧化型与还原型两种,Hcy 常在肾脏中合成、代谢。

Hcy 水平在糖尿病患者中作为疾病的预后评估,而高水平的Hcy 还会使血管的平滑肌细胞加快迁移、增殖,进而损伤到肾动脉血管,此外,高水平的Hcy 可降低肾微血管及血管内皮细胞的清除率,以此损伤到肾脏内皮血细胞及肾小球的底膜功能,因此,Hcy 水平升高是引起糖尿病肾病的危险因素[8]。

研究得出,A 组的Cys-C、CRP、Hcy 含量高于B 组,数据差异有统计学意义(P <0.05),分析原因,微量白蛋白尿是指尿中微量白蛋白在20~200mg/L 范围内,肾小球损伤初期,经过逆转纤维化治疗,可修复肾小球;而当尿中微量白蛋白超过200mg/L 时,说明患者已有大量白蛋白漏出,肾脏损伤较为严重。

2型糖尿病肾病的Cys-C 更高的原因可能是由于紊乱的血糖、血脂影响到肾小球过滤功能负荷,使其受损加重,体液中Cys-C 无法被吸收代谢,因此渗透到血液中使血液中的Cys-C 水平升高。

机体受到炎症刺激加重时,CRP 含量会因此增多,而2型糖尿病肾病患者属于2型糖尿病并发症的一种,病情有所进展,炎症会随病情加重而加重,CRP 含量也会随之升高。

Hcy 水平与肾脏受损程度有关,肾脏受损程度较高,Hcy 水平也会处于较高的水平,所以2型糖尿病肾病患者的Hcy 水平高于2型糖尿病患者。

中华医学杂志英文版投稿须知

中华医学杂志英文版投稿须知

Instructions for authorsChinese Medical Journal (CMJ) is an international, peer-reviewed general medical journal published in English semimonthly by the Chinese Medical Association and distributed worldwide. Manuscripts are welcome from any part of the world.MANUSCRIPT INFORMATIONManuscript requirementsManuscripts submitted to CMJ should meet the following criteria: the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data.Manuscript submissionAuthors are required to submit their manuscripts online at .Previous publication or duplicate submissionManuscripts are considered with the understanding that they have not been published previously and are not under consideration by another publication. Copies of possibly duplicative materials that have been previously published or are being considered elsewhere must be provided at the time of manuscript submission.Previous presentationA complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) can be considered.CATEGORIES OF ARTICLESCMJ publishes editorial, original article, review article, medical progress, brief report,viewpoint, case report, letter, and many other categories of articles. Topics of interest include all subjects that relate to the practice of medicine and research.EditorialThese are usually commissioned, however, unsolicited editorials are welcome. We are keen to consider editorials or ideas for editorials from authors outside China. Editorials should be up to 2000 words long with no more than 25 references.Original articleManuscripts on epidemiological studies, studies of social medicine, clinical trials, especially large scale randomized controlled trials are welcome. Each manuscript should clearly state an objective or hypothesis, the methods, the main results of the study and the conclusions. The length is limited to 2000–4000words (not including tables, figures, and references).More than 20 references are encouraged to be cited in this kind of articles.Meta analysisOnly results of meta analysis are reported in this kind of article. The length of the article is within 2000–4000 words (not including tables, figures, and references). Medical progressThis kind of article is mainly solicited, but we also consider unsolicited articles. The length of the article is within 2000–4000 words (not including tables, figures, and references).Review articleReview articles include systematic, critical assessments of literature and data sources pertaining to different medical topics, such as cause, diagnosis, prognosis, therapy, or prevention, etc.The length is limited to 2000–4000words (not including tables, figures, and references).Brief reportThese articles are short reports of original studies. They should not exceed 2500 words with no more than 2 tables and/or two illustrations and 15 references.Clinical experienceAuthors of these articles provide their experiences for diagnosis, treatment or prevention of diseases. The length is up to 2500 words with no more than 2 tables and/or two illustrations and 15 references.ViewpointPersonal views are welcome and the length should be 1000–3000 words (not including tables, figures, and references). Authors of this type of articles should sign their real names; no anonymous pieces are published.Case reportAuthors usually describe one to three patients or a single family. The text is limited to no more than 2500 words, and up to 15 references.Clinical solutionsThe articles are evidence-based reviews of topics relevant to practicing physicians. Articles in this series should include the following sections: case report, clinical overview, strategies, clinical difficulties, and author’s personal opinions. The text is limited to 3000 words and a small number of figures and tables. Images for diagnosisAuthors can provide here with typical images of common or uncommon medical conditions. This feature is intended to capture the sense of visual discovery and variety that physicians experience. It is not intended as a vehicle for case reports.LetterLetters to editors discussing a recent CMJ article should be received within 3 months of the article’s publication and should not exceed 500 words of text and 5 references. Letters should also be submitted online.AUTHOR INFORMATIONDesignate a corresponding author and provide a complete address,telephone and fax numbers, and E-mail address.Authorship requirementsEach author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based on(1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published.Conditions 1, 2, and 3 must all be met.1Group authorshipIf authorship is attributed to a group, all members of the group must meet the full criteria and requirements for authorship as described above. A group must designate at least one individual as corresponding author. Other group members may be listed in an Acknowledgment.Conflicts of interestAuthors should indicate relevant conflicts of interest, including specific financial interests relevant to the subject of their manuscript, in their covering letter. Authors without relevant financial interests in the manuscript should indicate no such interest.EDITORIAL REVIEW AND PUBLICATIONPeer reviewA CMJ editor reviews submitted manuscripts initially. Manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to expert consultants for peer review. Peer reviewer identities are kept confidential.The manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. We encourage authors to suggest the names of possible reviewers, but we reserve the right of final selection. Rejected manuscriptsRejected manuscripts and reasons for rejection can be found online. EditingAccepted manuscripts are copyedited first by native speakers and then by CMJ editors according to CMJ style and returned to the author for approval. Authors are responsible for all statements made in their work, including changes made by the editor and authorized by the corresponding author.PublicationAuthors are required to pay page fee if their manuscripts are accepted for publication. The publisher will provide the author (s) 2 copies of the journal free of charge.CopyrightThe Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of the Chinese Medical Association and may not be published elsewhere without written permission. Chinese Medical Association keeps the right to use these manuscripts in any form, including print, video, audio, and digital.MANUSCRIPT PREPARATIONManuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by the International Committee of Medical Journal Editors (ICMJE) ().Submit the original manuscript online; use 1 side of standard-sized page and 1.5 cm margins.For Chinese authors, submission of a Chinese version of the manuscript (or abstract) is recommended.Use only 10- or 12-point font size.On the title page include the full names and affiliations of all authors. If an author’s affiliation has changed since the work was done, list the new affiliation as well. Titles should be concise and descriptive. The name, address, telephone number, fax number, and E-mail address of the correspondence author should be addressed. Any grant support that requires acknowledgment should be mentioned on this page.Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury. All hematological and clinical chemistry measurements should be reported in the metric system in terms of the International System Units (SI).Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is directly relevant to the discussion.Do not use abbreviations in the title or abstract and limit their use in the text.A covering letter signed by all authors includes(1) information on prior or duplicate publication or submission elsewhere of any part of the study; (2) the statement that the manuscript has been read and approved by all the authors and that the criteria for authorship have been met; (3) the statement on financial or other conflict of interests; and (4) any suggestions such as referring possible unqualified reviewers due to conflict of interests, etc. The corresponding author must sign the acknowledgment statement. Authors should obtain written permission from all individuals named in an acknowledgment.JOURNAL STYLETablesTables should be simple and no duplicate information should appear in the text of the article. Tables should be numbered consecutively, and headed by a concise title. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Forfootnotes use the following symbols in this sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡.FiguresComplete sets of illustrations must be submitted with legends typed on the same page. Only clear photographs are acceptable. All lettering must be legible after reduction to column size. Magnification and staining should be indicated when pertinent. AbbreviationsUse only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.Ethical requirementFor experimental investigations of human subjects, state in the Methods section that an appropriate institutional review board approved the project. For those investigators who do not have formal ethics review committees,the principles outlined in the Declaration of Helsinki2 should be followed. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants.Patient descriptions, photographs, and pedigreesInclude a signed statement of informed consent to publish (in print and online) patient descriptions, photographs, and pedigrees from all persons (parents or legal guardians for minors) who can be identified in such written descriptions, photographs, or pedigrees. Such persons should be shown the manuscript before its submission.Permissions required to reproduce or adapt material Acknowledge all text, illustrations, and tables adapted or reproduced from other publications and submit permission from the original publishers(or other copyright owner) to republish in print, online, and licensed versions of CMJ.ReferencesNumber references in the order they appear in the text; do not alphabetize. In text, tables, and legends, identify references with superscript Arabic numerals. When listing references,abbreviate titles of journals according to Medline. Note: List authors and/or editors up to 6; if more than 6, list the first 6 authors followed by et al.Examples of reference style:1. Liu XP, Long DY, Dong JZ, Liu XQ, Fang DP, Hao P, et al. Recurrent atrial tachycardia and atrial fibrillation after circumferential pulmonary vein a blation: What’s the difference? Chin Med J 2005; 118: 1773-1778.2. Xie SZ, Gu MJ, Cheng YP. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm. Chin J Obstet Gynecol (Chin)* 1998; 33: 113-114.3. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974: 457-472.4. Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11 Suppl 2: s369-s378.5. Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2): 89-97.6. Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995;32 (Pt 3): 303-306.7. Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-114.8. Cumulative number of reported cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. (Accessed April 9, 2003 at http://www.who.int/csr/sarscountry/ 2003_04_04/en/.)*: It is especially needed to note “(Chin)” for articles published in Chinese.Authors are responsible for the accuracy and completeness of their references and for correct citation of the text.REPORT OF ORIGINAL DATAAbstractInclude a structured abstract of no more than 300words for original articles, meta analysis, brief report, clinical experience (Background, Methods, Results, Conclusions) and review articles (Objective, Data sources, Study selection, Results, Conclusions); an informative abstract for medical progress, viewpoint, case report, clinical solutions and images for diagnosis.KeywordsThree to 6 words or short phrases should be provided at the top of the abstract page as keywords. Terms from the medical subject heading (MeSH) list of Medline should be used; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used.IntroductionIntroduction should be short and arresting. State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.MethodsDescribe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex, and other important characteristics of the subjects.Iden tify the methods, apparatus (list the manufacturer’s name and original country in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate theirlimitations. Identify precisely all drugs and chemicals used, including generic name (s), dose (s), and route (s) of administration.Reports of randomized clinical trials should present information on all major study elements including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding). Authors are recommended to refer to the CONSORT Statement 3 for details.ResultsOverall describe the major findings of the study. Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. DiscussionSummarize the major findings. Discuss possible problems with the methods used. Compare your results with previous work. Discuss the clinical and scientific (if any) implications of your findings and their limitations. Suggest further work. Produce a succinct conclusion.MANUSCRIPT CHECKLISTSubmit complete text of your manuscript online (including tables, figures, etc), in addition, domestic authors should submit Chinese version of the complete text or its abstract.Review the sequence: covering letter, title page, key words and abstract, text, acknowledgments, references, tables, legends for illustrations.Check all references for accuracy and completeness. Put references in proper format in numerical order, making sure each is cited in the text.Include written permission from each individual identified as a source for personal communication.Include informed consent forms for identifiable patient descriptions, photographs and pedigrees.Keep copies of everything submitted.Manuscript inquiriesTel:86-10-85158321.Fax:86-10-85158333.Email:***********. cn.REFERENCES1.International Committee of Medical Journal Editors. Uniformrequirements for manuscripts submitted to biomedical journals.(Accessed September 10, 2009 at: )2.World Medical Association. Declaration of Helsinki: Ethicalprinciples for medical research involving human subjects.(Accessed September 6, 2005 at: /e/policy/ pdf/ 17c.pdf)3.Schulz KF, Altman DG, Moher D, for the CONSORT Group.The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (Accessed October 28, 2010 at: http://www.consort- )。

《中华医学》杂志投稿须知

《中华医学》杂志投稿须知
LIN Xianyan* , WU Jianping, QIN Jiong, et al. * Department of Pediatrics, First
Hospital, Peking University, Beijing 100034, China。
4.关键词:论著需标引2~5个关键词。请尽量使用美国国立医学图书馆编辑的最新版Index Medicus中医学主题词表(MeSH)内所列的词。必要时,可采用习用的自由词并排列于最后。
3.摘要:论著需附中、英文摘要,摘要必须包括目的、方法、结果(应给出主要数据)及结论四部分,各部分冠以相应的标题。采用第三人称撰写,不用“本文”等主语。中文摘要可简略些(250字左右),英文摘要应稍详细一些(400个实词左右)。英文摘要前需列出英文题名、作者姓名(汉语拼音,姓的每个字母均大写,名字首字母大写,双字名中间不加连字符)、第一作者单位名称、所在城市名、邮政编码和国名。作者应列出前3位,3位以上加“,et al”;不属同一单位时,在第一作者姓名右上角加“*”,同时在单位名称首字母左上角加“*”,例如:
8.来稿一律文责自负。根据《著作权法》,《中华医学杂志》对决定刊用的文稿可作文字修改、删节,凡有涉及原意的修改,则提请作者考虑。对退修的文稿,要求作者将修改稿以纯文本格式存入软盘,将文件名标注在软盘上,与修改稿打印件一并寄回《中华医学杂志》编辑部;或利用《中华医学杂志》电子信箱传送修改稿。修改稿首页须Байду номын сангаас明稿件编号。修改稿逾2个月不返回本编辑部者,视作自动撤稿。
9.来稿决定刊用后,由作者亲笔签署论文专有使用权授权书,专有使用权即归中华医学会所有。除以纸载体形式出版外,中华医学会有权以光盘、网络期刊等其他方式出版决定刊用的文稿。

《中国保健》医学研究版征稿启事

《中国保健》医学研究版征稿启事

不 足 与 浪 费并 存 的 现 象n 要 解 开 当前 一 团 乱 麻 的 现 状 就 要


消除逐 利心 态
首先是政府应放下广义 的
逐 利 “

心态



幅增加财政投入 合理 配 置 卫 生投入 和 医疗 资源 遏 制公立


医院的逐 利趋 向 ,
使之 回归 公益 的 轨道 ;
要加强 监 管手段 ,


我 国在近几 年社会办 医事业 发展迅 猛 社 会办 医疗机构数量 .
增长快速 ,
同时 ,
社会医疗机构在发展壮大过程 中 .
也 暴露
出本 身存 在 的许 多 问题 。 一 是 社 会 医 疗 机 构 恶 性 竞 争呈 上 升
态势 社会 信任度不 足 有些 社 会 医疗 机 构为 了求生 存 采



公共产 品和服务 提供公 共产 品和公 共服务是政府的责任


然而 随着我 国医 药卫 生 体制改革 的进 行 我 国 的政 府职 能


转变不到位 政 府的主导作用没有发挥 市场机制也 不可 能


完整 的建立 起来 现行公立 医 院所利用 的市场机制的作用 是 ,
扭 曲的和失灵 的 。
加强政府导 向 。



3 对我国公立 医院改革发展中存在同墨 的思考
3 1 政 府 导向厦 卫 生投 入 .
随着我 国市 场经 济体制改革不 断发 展 和深 入 以 市场 为 .
导向的医疗体制改革 使得我 国医疗资源逐 渐分化 由此 所


产 生 的 以 公益 性 公 平性 弱 化为 主 的 一 系列 问 题 日益 凸 现
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

《中华保健医学杂志》投稿须知
1 文稿应具有科学性、逻辑性、实用性、论点明确、资料可靠。

文字精练、层次清楚、数据准确、重点突出。

论著一般不超过4 000字,经验交流、病例报告、医学保健工作探索、短篇报道、一般以1 500字为宜。

文稿属“国家基金项目”、“中标课题”等,请在脚注标明,包括编号。

2 文题应力求简明、醒目、反映文章的主题。

中文文题一般不超过20个字,最好不设副题。

3 作者应是文章撰写的参与者,作者署名表示责任(文责自负)与权利(著作权)。

作者姓名在文题下按序排列,每篇文章作者数不超过6位。

通讯作者只列1位,并在论文首页脚注Email信箱。

作者单位需写全称、并注明所在地和邮编。

第一作者附上作者简介,含姓名、性别、出生年月、籍贯、技术职务、所从事的专业,脚注在文稿第1页下方。

4 论著须附中、英文摘要,包括目的、方法、结果(应给出主要数据)、结论四部分,采用第三人称撰写。

中文摘要300字左右,英文摘要400个实词左右,与中文摘要内容相对应。

英文摘要包括文题、作者姓名(汉语拼音)、单位名称、所在地名、邮政编码。

应列出全部作者的姓名。

如作者工作单位不同,只列出第一作者的工作单位。

5 关键词论著应标出3~5个中、英文关键词,关键词之间用“;”分隔,请尽量参照中国医学科学院医学情报研究所编译的《医学主题词注释字顺表》和人民军医出版社出版的《军用医学主题词表》,英文译名使用美国国立医学图书馆编辑的最新版(Index Medicus)的医学主题词表(MeSH)内所列的词。

每个英文关键词首个字母大写,多个关键词之间应用分号“;”分隔。

6 正文论著格式一般分为对象与方法、结果、讨论等三部分。

经验交流应有中文摘要,正文格式与论著同。

个案报道一般分为临床资料和讨论两部分。

7 医学名词以全国自然科学名词审定委员会公布的《医学名词》为准,尚未审定公布者以人民卫生出版社出版的《英汉医学词汇》为准。

中文药物名称应使用最新版《药典》(法定药物)或卫生部药典委员会编辑的《药名词汇》(非法定药物)中的名称。

英文药物名称则采用国际非专利名称,不用商品名。

文稿内使用的名词术语前后应统一,以全国自然科学名词审定委员会公布的名词为准,如原词过长且文内又多次出现者,可于首次出现时写全称,在圆括号内注明英文及简称,再出现时则用简称。

括号内英文,除专有名词外,一律用小写。

例如:脑梗死(cerebral infarction,CD)。

公认通用缩略语可直接应用,如DNA、RNA、IgG等。

文题中一般不使用缩略语,正文中尽量少用。

8 图表力求简洁明确,避免与文字重复。

表格采用三线表,应有表序和表题,按统计学原则制表,内容简明、数据准确、有效位数一致。

以计算机制图者
提供激光打印图样及光盘。

照片务求清晰度、对比反差明显,并在背面用铅笔注明文题、作者、序号、及上下端标志,用另纸粘贴置于正文之后。

大体标本照片在图中有尺度标示。

病理照片要求注明染色方法和放大倍数。

9 统计学应写明所用统计方法的具体名称,统计学符号按GB3358-82《统计学名词及符号》规定书写。

应写明所用统计分析方法的具体名称,如析因设计资料的方差分析,成组设计资料的t检验等。

要注意区分百分率与百分比。

10 计量单位按国务院1984年2月颁布的《中华人民共和国法定计量单位》规定书写,具体使用参照中华医学会编辑出版部编辑的《法定计量单位在医学上的应用》一书。

在一个组合单位代号内不得有一条以上的斜线,如ng/kg/min应改写为ng.kg-1.min-1的形式,压力的计量单位一律使用mmHg,但首次使用时应注明mmHg与kPa的换算系数(1 mmHg=0.133 kPa)。

11 数字执行国家标准GB/T15835-1995《关于出版物上数字用法的规定》。

公历世纪、年代、年、月、日、时刻和计数、计量均用阿拉伯数字。

小数点前或后超过3位数字时,每3位数字一节,节间空1/4个汉字,如:“61,329.476,56”应写成“61 329.476 56”。

但序数词和年份、页数、部队番号、仪表型号、标准号不分节。

百分数的范围和偏差,前一个数字的百分符号不能省略,应写成5%~95%,50.2%±0.6%可写成(50.2±0.6)%。

附带尺寸单位的数值相乘,按下列方式书写:4 cm× 3 cm × 5 cm。

12 参考文献必须是作者参阅过的近5年内发表的文献。

凡是摘要、二次文献(如国外医学系列期刊等)、内部资料及未公开发行的书及刊物的文章不能作为参考文献。

引用文献,论著一般不超过10条,综述20条,其他不超过5~7条。

参考文献作者3名以内全部列出,3名以上只列前3名,后加“等”或“et al”字样,外文期刊名称用缩写,以《Index Medi?鄄cus》的格式为准;中文期刊用全名。

每条参考文献均须著录起止页次。

每条文献题名或书名后加文献类型标识码:专著[M],论文集[C],报纸文章[N],期刊文章[J],学位论文[D],报告[R],标准[S],专利[P]等。

著录格式:
出版物(期刊)的著录格式:著者.题名[文献类别标识码].刊名,年,卷:起止页。

例如:
1 郑秋甫,郑延松,彦小荣,等. 同型半胱氨酸对血管内皮细胞表达和分泌TRPT的影响[J]. 解放军医学杂志,2004,29:159-163.
2 Lefebvre P,Lierneux B,Lenaerts L,et al. Cerebral venous thrombosis and procoagulant factors a case study[J]. Angiolo?鄄gy,1998,49:563-568.
专著(书)著录格式:著者.书名[M].版本(第1版省略). 出版社,出版年.
起止页。

例如:
1 牟善初,陶国枢主编. 现代老年急症学[M]. 北京:人民军医出版社,1997.693-707.
2 Stemberger LM. Immunhistochemistry[M]. 2nd ed. New York:John Wiley and Sons,1979.104-108.
注意事项
1 来稿须经作者单位审核并附正式推荐介绍信。

推荐信应注明无一稿两投,不涉及保密等。

并应注明详细通讯地址、邮政编码、联系电话、自留底稿,恕不退稿。

2 来稿应用文字打印稿或电子邮件,不受理复写稿及传真稿。

打印稿应一式两份,用A4纸,四号字,1.5倍行距,以非稿纸格式打印,只用非稿纸单面,不得两面打印。

电子邮件请发至本刊电子信箱。

3 来稿请投统一邮箱:zhbjyx@。

编辑部收到稿件1个月内发出修改通知或退稿通知。

超过2个月未收到退、修文稿时,请及时向编辑部查询。

修改稿应附软盘(或发电子邮件)一并寄编辑部。

作者如欲他投,请事先与本刊编辑部联系。

4 来稿一律文责自负。

依照《著作权法》有关规定,本刊编辑部可对来稿作文字修改,删节,凡有涉及原意的修改,则提请作者考虑。

5 来稿经编辑部登记编号后,寄给作者“回执”,以便日后查询。

6稿件确认刊载后需按通知数额付版面费,编辑部将出具版面费发票。

赠当期杂志1册并酌致稿酬,均寄第一作者。

相关文档
最新文档